update, page-5

Interesting announcement. Good news on the TGA audit side. These audits are not difficult to pass, just a bureaucratic pain in the proverbial.

The announcement in regards to the technical improvements raises some questions though. It's hard to be too enthused about an improvement to facilitate reagent transfers via multichannel pipettes as opposed to single channel pipettes. This is akin to BHP announcing it plans to open a new mine and use a shovel for digging instead of a stick!

For widespread adoption into a pathology lab any test must be as automated and self-contained as possible. The mere mention of delaying initial clinical testing to move away from single channel pipettes suggests the functionality of PapType in a commercial setting may not have been fully considered.